With the growing prevalence of nonalcoholic fatty liver disease (NAFLD) and its more severe form, nonalcoholic steatohepatitis (NASH), there is increasing interest in medications that impact metabolism. Among these, Rezdiffra (resmetirom) has attracted attention—not only for its approved role in treating NASH but also for questions regarding its potential impact on body weight. One especially … Read more
Debunking Rumors, Addressing “Too Skinny” Claims, and Setting Realistic Expectations Philip DeFranco’s weight loss has been one of the most talked-about physical transformations on YouTube in recent years. As his appearance changed gradually on camera, speculation followed just as steadily. Fans praised his discipline, critics questioned his health, and rumors spread across Reddit, Twitter, and … Read more
As new treatments emerge for metabolic liver diseases like nonalcoholic steatohepatitis (NASH), patients often wonder not only about disease improvement but also about how these medications might affect their weight and body composition. One of the most frequently asked questions is: “What does Rezdiffra weight loss before and after look like for patients—does this drug … Read more
Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH), are among the most common liver conditions worldwide. These disorders are closely linked with obesity, insulin resistance, type 2 diabetes, and excess fat around the abdomen—often referred to by patients as belly fat. With recent advances in pharmacotherapy, new drugs like Rezdiffra (resmetirom) … Read more
Meal Ideas, Practical Nutrition Habits, and How His Approach Compares to Popular Diets Philip DeFranco’s weight loss journey sparked curiosity not just about workouts, but about food. Viewers wanted to know: What did he actually eat? Did he follow a strict plan? Was there a special diet involved? What makes Philip DeFranco’s diet approach interesting … Read more
With the rapid rise of metabolic disorders such as obesity, type 2 diabetes, and fatty liver disease, medications that influence metabolism often attract attention beyond their original purpose. Two such medications frequently compared online are Rezdiffra (resmetirom) and Ozempic (semaglutide). A common question asked by patients and readers alike is: Rezdiffra vs Ozempic for weight … Read more
Practical Lessons, Common Pitfalls, and Realistic Plans for Real Life Philip DeFranco’s weight loss journey has become one of the most discussed creator transformations of the past few years. Unlike viral “30-day” makeovers or extreme before-and-after stories, his progress stood out for one key reason: it looked real. Over time, viewers didn’t just see physical … Read more
With increasing awareness of nonalcoholic steatohepatitis (NASH) and the advent of new treatment options, many people are curious about the broader metabolic effects of these therapies. One question that frequently appears in online searches is: What do clinical trials show about Rezdiffra weight loss results? In this article, we’ll explore what clinical trials have actually … Read more
A Year-by-Year Look at His Transformation, Training Evolution, and Public Reaction Philip DeFranco’s fitness journey didn’t unfold in a single viral moment. It was gradual, layered, and highly visible to millions of viewers who had followed him for years. From 2021 through 2025, fans noticed steady physical changes — but also shifts in energy, confidence, … Read more
With the recent FDA approval of Rezdiffra (resmetirom) for the treatment of nonalcoholic steatohepatitis (NASH) with fibrosis, interest in this new medication has grown rapidly—not only among liver specialists but also among patients searching online. One of the most commonly asked questions is: Does Rezdiffra cause weight loss, or is weight loss just a side … Read more